New to Meducation?
Sign up
Already signed up? Log In
view moderators

MultipleSclerosis

Category

Preview
0
18

Epilepsy drug may preserve eyesight for people with MS

A drug commonly taken to prevent seizures in epilepsy may surprisingly protect the eyesight of people with multiple sclerosis (MS), according to a study released April 16, 2015 that will be...  
medicalnewstoday.com
almost 5 years ago
Preview
0
2

Blood pressure drug protects against symptoms of multiple sclerosis in animal models

FDA-approved drug prevents myelin loss and alleviates symptoms of MS by enhancing innate cellular protective responseAn FDA-approved drug for high blood pressure...  
medicalnewstoday.com
almost 5 years ago
Preview
0
9

Tackling autoimmune diseases and chronic inflammation

Multiple sclerosis, type 1 diabetes and lupus have one thing in common: They are all autoimmune diseases in which the immune cells can no longer differentiate between friend or foe and thus...  
medicalnewstoday.com
almost 5 years ago
Preview
0
5

Drugs stimulate body's own stem cells to replace the brain cells lost in multiple sclerosis

A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by...  
medicalnewstoday.com
almost 5 years ago
Preview
0
9

What happens when multiple sclerosis patients stop taking their medication?

New research led by NYU Langone Medical Center examines what happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication.  
medicalnewstoday.com
almost 5 years ago
Preview
0
5

FDA approves first generic Copaxone to treat multiple sclerosis

The U.S. Food and Drug Administration has approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).  
medicalnewstoday.com
almost 5 years ago
Preview
0
7

Experimental drug that may repair nerve damage in MS moves forward

A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves and is damaged in MS, according to a study released...  
medicalnewstoday.com
almost 5 years ago
Preview
0
8

Multiple sclerosis patients could benefit from brain boost study

Multiple sclerosis patients could one day benefit from treatments that boost their brain function, a study suggests.  
medicalnewstoday.com
almost 5 years ago
Preview
0
3

Study monitors walking activity in people with MS

PatientsLikeMe has announced results of a novel study conducted with Biogen that showed how people living with multiple sclerosis (MS) can use wearable activity tracking devices to collect and...  
medicalnewstoday.com
almost 5 years ago
Preview
0
3

£1.1m study to reduce cognitive problems in people with MS

Experts in Nottingham are leading a major new study into how people with multiple sclerosis (MS) could overcome problems with attention and memory associated to their condition.  
medicalnewstoday.com
almost 5 years ago
Preview
0
2

New anti-inflammatory molecule could halt MS progression

Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).  
medicalnewstoday.com
almost 5 years ago
Preview
0
11

From chick to bedside: Removing the Wnt barrier

Kick starting a process that might repair the damage done in cerebral palsy and multiple sclerosis could begin with disabling a driver that helps block regeneration, said Baylor College of...  
medicalnewstoday.com
almost 5 years ago
Preview
0
5

Strong genetic risk factor for MS discovered in family of five affected siblings

Researchers at the University of Illinois at Chicago have identified a genetic variation that in women significantly increases their risk of developing multiple sclerosis.  
medicalnewstoday.com
almost 5 years ago
Preview
0
16

Myelin-maker: How an FDA-approved drug boosts myelin synthesis

Damage to myelin, the fatty insulator that enables communication between nerve cells, characterizes multiple sclerosis (MS) and other devastating neurological diseases.  
medicalnewstoday.com
almost 5 years ago
Preview
0
12

Multiple sclerosis: becoming aware of its invisible difficulties

For National Multiple Sclerosis Awareness Week, we take a closer look at a complex and elusive condition and the difficulties that exist in its diagnosis and treatment.  
medicalnewstoday.com
almost 5 years ago
Preview
0
2

'First Clinical Evidence' of Remyelination in MS

Researchers report what they call 'the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis': improved optic nerve conduction in optic neuritis.  
medscape.com
almost 5 years ago
Preview
0
31

'First Clinical Evidence' of Remyelination in MS

Researchers report what they call 'the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis': improved optic nerve conduction in optic neuritis.  
medscape.com
almost 5 years ago
Preview
0
0

'First Clinical Evidence' of Remyelination in MS

Researchers report what they call 'the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis': improved optic nerve conduction in optic neuritis.  
medscape.com
almost 5 years ago
Preview
0
7

FDA Approves First Generic Copaxone in Multiple Sclerosis

A generic version of the standard MS therapy glatiramer acetate receives FDA approval.  
medscape.com
almost 5 years ago
Preview
0
4

MS drug 'may already be out there' | Nursing in Practice

Depression and heart-disease drugs are to be tested in a trial to find treatments for multiple sclerosis (MS) from existing medicines. There are currently no treatments in the secondary progressive stage of the debilitating disease. Doctors hope the necessary drugs are already out there, but have never been tested on MS.  
nursinginpractice.com
almost 5 years ago